# OnCo record nmpa-cde (institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/institutions/nmpa-cde/>
  a schema:MedicalOrganization ;
  onco:kind "institution" ;
  schema:identifier "nmpa-cde" ;
  schema:name "National Medical Products Administration / Center for Drug Evaluation"@en ;
  schema:alternateName "NMPA"@en, "CDE"@en, "CFDA"@en, "China FDA"@en ;
  schema:description "China's drug regulator and its review centre, whose reforms since 2015 turned China into the world's second-largest source of new cancer drugs and a leader in ADCs and bispecifics."@en ;
  schema:url <https://onco.cc/institutions/nmpa-cde/>, <https://www.cde.org.cn> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:citation <https://www.cde.org.cn>, <https://www.nmpa.gov.cn> ;
  schema:addressCountry "CN" ;
  schema:addressLocality "Beijing" ;
  schema:latitude "39.904"^^xsd:decimal ;
  schema:longitude "116.407"^^xsd:decimal ;
  onco:technologies <https://onco.cc/technologies/adc/>, <https://onco.cc/technologies/bispecific-antibody/>, <https://onco.cc/technologies/car-t/> ;
  onco:drugs <https://onco.cc/drugs/ivonescimab/>, <https://onco.cc/drugs/disitamab-vedotin/> ;
  onco:companies <https://onco.cc/companies/akeso/>, <https://onco.cc/companies/beone/>, <https://onco.cc/companies/kelun-biotech/> ;
  onco:institutions <https://onco.cc/institutions/csco/>, <https://onco.cc/institutions/cams-cancer-hospital/>, <https://onco.cc/institutions/sysucc/>, <https://onco.cc/institutions/fuscc/>, <https://onco.cc/institutions/fda-oce/> ;
  onco:people <https://onco.cc/people/huang-guo/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-regulatory-fragmentation/>, <https://onco.cc/bottlenecks/b-trial-diversity/> .